Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Arpit SharmaDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0000-0001-6912-8131
Md Al AminDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0009-0009-7487-2139
Man B KshetriDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0000-0002-4673-4662
Suha AlqarniDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0000-0001-7923-9257
Wjdan JogadiDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0009-0009-0503-2961
Jordan SolmenDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.
Zexin LinDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0009-0001-4164-4713
Shirin AkterDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.ORCID 0009-0001-0158-8091
Yao-Rong ZhengDepartment of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.
Funding
Development of Novel Metal-Based Supramolecular Therapeutics for Ovarian CancerR15CA249712 · NCI · KENT STATE UNIVERSITY · PI ZHENG, YAORONG · 2021 to 2021
$455k
Light-Controlled Supramolecular Platinum Complexes for Biomedical ApplicationsR15GM152919 · NIGMS · KENT STATE UNIVERSITY · PI ZHENG, YAORONG · 2024 to 2024
$434k
Kent State University Farris Family Innovation FellowshipKent State University LaunchPad AwardNCI NIH HHS R15 CA249712NIGMS NIH HHS R15 GM152919NIH HHS 1R15CA249712-01A1NIH HHS 1R15GM152919-01
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
PEGylation Effects on Amphiphilic Platinum(IV) Complexes: Influence on Uptake, Activation, and Cytotoxicity. · full record | OpenQuestion